Go to
JCI Insight
Citations to this article
Fanny Mochel, Ronald G. Haller
Published February 1, 2011
Citation Information: J Clin Invest. 2011;121(2):493-499. https://doi.org/10.1172/JCI45691.
Citation Information: J Clin Invest. 2011;121(2):493-499. https://doi.org/10.1172/JCI45691.
Abstract
Huntington disease (HD) is an autosomal dominant neurodegenerative disease with complete penetrance. Although the understanding of the cellular mechanisms that drive neurodegeneration in HD and account for the characteristic pattern of neuronal vulnerability is incomplete, defects in energy metabolism, particularly mitochondrial function, represent a common thread in studies of HD pathogenesis in humans and animal models. Here we review the clinical, biochemical, and molecular evidence of an energy deficit in HD and discuss the mechanisms underlying mitochondrial and related alterations.
Authors
Fanny Mochel, Ronald G. Haller
Total citations by year
Citation information
Citations to this article in year 2013 (10)
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)